H
EMANGIOBLASTOMAS (HBL's) are rare tumors of the central nervous system (CNS), accounting for only 1% to 2.5% of all intracranial neoplasms. 1~ The tumor is predominantly located in the cerebellum (Lindau tumor) , but is also found in other regions of the CNS. Although histologically benign and slow-growing, HBL's tend to cause life-threatening complications due to expansion of peritumoral cysts. Hemangioblastomas occur either sporadically or as a manifestation of von Hippel-Lindau syndrome, 5 an autosomally dominant, inherited disorder characterized by tumors or tumor-like lesions developing in several organs, including angiomatosis of the retina (von Hippel disease), pheochromocytoma, renal cysts or renal carcinoma, and pancreatic cysts or carcinoma of the pancreas. 5.6
A 10-year study of 47 HBL's of the CNS in 44 patients is reported, with special emphasis on the clinical symptoms, neuroradiological features, and microneurosurgical treatment. The frequent association of this tumor entity with the von Hippel-Lindau syndrome is stressed. In addition to the catamnestic data, a screening program is presented which we believe should be performed for every patient presenting with HBL of the CNS in order to identify individuals suffering from, and families at risk for, von Hippel-Lindau syndrome.
Clinical Material and Methods
All patients included in this study underwent neurosurgical treatment for HBL of the CNS in the neurosurgery department of our hospital during the period from August 31, 1976, to September 1, 1986 . A final follow-up examination was conducted on every patient in 1986 or 1987. The data analyzed included the clinical history, neurological and ophthalmological findings, and postoperative and long-term prognoses. The possibility of von Hippel-Lindau syndrome was explored by collecting data on the family history and by pedigree analysis. Patients, their relatives, and their physicians were contacted and interviewed. A screening program was offered to all affected individuals and to first-degree relatives of patients who presented with signs of the syndrome (Table 1) .
Graph showing the cumulative age distribution of the 44 patients in this series with hemangioblastomas (HBL's) of the central nervous system. Open circles = all 44 cases of HBL; filled circles = HBL's associated with von Hippel-Lindau syndrome (10 cases); crosses = sporadic HBL's (34 cases). Abscissa = age at diagnosis (years); left ordinate = total number (n) of cases (note that different scales are being used for the three HBL groups); right ordinate = cumulative incidence in percentages. 
Results
D u r i n g the 10-year period o f this study, 44 patients with 47 t u m o r s were treated for H B L of the CNS at our hospital. This figure corresponds to an incidence of approximately four cases per year a n d represents 0.8% of all CNS t u m o r s operated o n during the period of study. The sex distribution shows 21 males and 23 females. The youngest p a t i e n t was 12 years of age and the oldest was 71 years old ( m e a n age 42.4 years). A significant difference in the age at diagnosis was noted between patients with sporadic H B L a n d patients with H B L associated with v o n H i p p e l -L i n d a u s y n d r o m e ( m e a n age 47 years a n d 29 years, respectively). The c u m u l a t i v e age distribution is s h o w n in Fig. 1 . In all patients, histopathological e v a l u a t i o n of t u m o r tissue c o n f i r m e d the diagnosis. Eighty-three percent of the t u m o r s were located in the cerebellum, a n d 13% were within the spinal canal (Table 2) .
Cerebellar H e m a n g i o b l a s t o m a
T h i r t y -n i n e cerebellar H B L ' s ( L i n d a u tumors) were observed in 36 patients. The clinical s y m p t o m s are listed in Table 3 . T h e interval between the appearance of initial symptoms and diagnosis varied from 3 to 100 weeks (mean interval 25.1 weeks). During the 10-year period of this study, the preoperative interval did not decrease significantly. Forty percent of the patients underwent various diagnostic and therapeutic procedures including gastroscopy, chiropractic maneuvers, and psychosomatic treatment before being referred to a neurosurgeon. Ophthalmological examination disclosed papilledema in 39% and horizontal nystagmus in 31% of the patients. Preoperatively, angiomatosis of the retina was observed in six cases. Cranial computerized tomography (CT) scanning had been performed in 35 patients with 37 HBL's. Thirty-two tumors were cystic and five were solid. Ninety-seven percent of the cystic tumors were visible on the CT scan, with the average size of the cysts being 40 x 45 mm. Occlusive hydrocephalus was found in 77% of these cases. Injection of contrast medium disclosed a solid tumor mass in 83% of the HBL's. Angiography revealed this solid tumor component in almost every case (95%). The tumor size was highly variable, ranging from 0.5 to 56.8 cu cm (average tumor size 2 cu cm). Nine HBL's (23%) were located in the midline of the cerebellum, and the remainder were in the cerebellar hemispheres. Magnetic resonance (MR) imaging was performed in three cases and consistently demonstrated both the cystic and the solid tumor portions.
In order to relieve occlusive hydrocephalus, ventriculoatrial shunts were implanted in half of the patients. Thirty-nine HBL's were removed with microsurgical operative technique. Complications developed in six patients (16 %): postoperative hematomas in three cases (two of which were fatal); local infections in two cases; and permanent gait disturbance in one case. A 12-yearold girl was treated for a contralateral cerebellar HBL 2 years after the first operation.
Follow-up interviews and clinical examinations were conducted 5 years after the operation. Thirty-two patients (89%) presented in good condition without major residual symptoms. One patient died of a heart attack 7 years after the surgery.
Extracerebellar Hemangioblastomas of the CNS
Intracranial extracerebellar HBL's were observed in two cases. One patient was a 35-year-old woman with a 30-week history of headache, amenorrhea, and diabetes insipidus. She suffered from a solid HBL of the pituitary stalk which was detected by CT scanning and angiography. The other was a 35-year-old man with a 20-week history of headache, vomiting, and ataxia. He presented with a cystic 4 x 5-cm tumor in the medulla oblongata.
Spinal HBL's were found in six cases. The symptoms, tumor location, and diagnostic procedures in these six cases are summarized in Table 4 . Two of these tumors were located in the cervical cord, and the remaining four were in the thoracic spinal cord. Spinal HBL's were detected by myelography angiography and/or CT scanning. Three of these tumors caused subarachnoid hem- orrhage as the initial symptom. Postoperatively, four patients recovered very well, one showed minor neurological impairment, and one with residual paraplegia died 6 years after neurosurgical intervention.
Von Hippel-Lindau Syndrome
Based on a review of 338 cases reported in the literature (Table 5 ), 9 family histories were explored with special attention to lesions of and treatment for diseases of the CNS, eyes, kidneys, adrenal glands, and pancreas. Only two patients reported a positive family history during the initial interview and were familiar with the hereditary nature of the disease (Families I and II, Table  6 ). In five cases, other family members were afflicted with tumors that are associated with von Hippel-Lindau syndrome but were unaware of the heredity of the disease (Families III, IV, V, VI, and VII). One patient presented with angiomatosis of the retina in addition to cerebellar HBL (Family VIII). The screening program for von Hippel-Lindau syndrome, which was offered to all patients with HBL of the CNS, was completed in 20 patients; 10 additional patients participated but did not receive all the examinations listed in Table 1 . The following lesions were detected: angiomatosis of the retina in one patient, pancreatic cysts in two, renal cysts in two, and renal carcinoma in one. Screening for von Hippel-Lindau syndrome stigmata was also offered to all first-degree relatives of patients with CNS HBL. In this group, angiomatosis of the retina was detected in five, pheochromocytoma in two, and pancreatic cysts in one. In addition, cranial CT scans revealed a cystic cerebellar HBL in a patient with retinal angiomatosis (Fig. 2 and Table 6 , Family IX).
Two families are described in more detail to demonstrate the importance of systematic family examination. In Family VII (Fig. 3 left and Table 6 ), a daughter was operated on for cerebellar HBL at the age of 12 years and died postoperatively from intracerebral hemorrhage. A detailed family history obtained during the preoperative interview was negative. However, it was noticed that she also suffered from angiomatosis retinae, which strongly suggested the presence of yon Hippel-Lindau syndrome. Her local physician was contacted but could not be convinced to recruit the family for our screening program. One year later, the mother of this patient was referred by another physician because of a long history of headache, vomiting, ataxia, and dysarthria. A cerebellar HBL was found. Clinical examination of this woman also revealed pancreatic cysts, renal cysts, and angiomatosis of the retina. Sub- nephew, a second pheochromocytoma in his brother, and angiomatosis of the retina in the mother. This family is remarkable in that each affected member developed only one manifestation of von Hippel-Lindau syndrome, with a predominance of pheochromocytoma. In summary, careful evaluation of the family history and systematic screening for signs of von Hippel-Lindau syndrome in patients with CNS HBL and their families revealed von Hippel-Lindau syndrome in 10 cases (23% of the patients in our series). By offering a screening program to affected families, 15 clinically silent manifestations of the syndrome were discovered (Table 6) . When comparing HBL patients with associated von Hippel-Lindau syndrome to patients with sporadic HBL a significant difference in the mean age at diagnosis was noted (29 years vs. 47 years, respectively). Multifocal CNS lesions were found in only four patients with von Hippel-Lindau syndrome, suggesting that multiple HBL's are highly suspicious of the syndrome. However, significant differences between sporadic and hereditary HBL's were not noted in the histopathological findings, radiological features, duration of symptoms, or distribution of the tumors within the CNS.
Discussion
Patients with HBL of the brain usually present with a longer history of minor neurological symptoms which, in many cases, are followed by a sudden exacerbation necessitating immediate neurosurgical intervention. Although improved radiological imaging techniques such as CT scanning and MR imaging became available during the course of this investigation, the average interval of 25 weeks between initial symptoms and diagnosis of the tumor did not change significantly. Ninety-four percent of posterior fossa HBL's caused clinical signs of cerebellar involvement. This is in agreement with data published by Constans, et al., 2 who reported similar latency periods. In most patients, the correct diagnosis was made only after the appearance of acute signs of increased intracranial pressure due to occlusive hydrocephalus. Consequently, 50% of our patients had to be admitted for emergency treatment. These emergencies could be avoided if patients presenting with focal cerebellar symptoms were examined neurologically and neuroradiologically. With broad availability of CT scanners and MR imaging systems, earlier detection of CNS HBL's might thus be possible. None of the intracranial HBL's in our series caused symptomatic subarachnoid hemorrhage; this is in contrast to the spinal tumors, 50% of which presented with signs of acute subarachnoid bleeding.
Thirteen percent of the HBL's in this study were located in the spinal canal. The same proportion of spinal HBL's were reported by Browne, et al.,l whereas Palmer I~ found that only 1% of CNS HBL's were located at this site. This discrepancy is at present not resolved. Cranial CT scanning has proved to be a reliable and accurate diagnostic procedure for identifying HBL's of the CNS. The tumor was detected in all cases where CT scans were available. Visualization of small solid tumor masses within basal regions of the biventer lobule was occasionally hampered by interference of the overlying petrous bone. Magnetic resonance imaging carried out in three of the most recent cases reliably demonstrated both solid and cystic tumor components; MR imaging may also be superior in detecting small solid HBL foci.
All HBL's were removed with microsurgical operative techniques. This approach yielded excellent postoperative results, with only three patients (7%) developing serious complications. These figures are similar to results published by Palmer 1~ and Constans, et al., 2 who reported an 8% and 10% postoperative mortality rate, respectively. When comparing classical and microsurgical techniques, Miiller-Jensen and coworkers 8 noticed a 13% fatality rate with the former and no postoperative fatalities in 12 patients treated microsurgically. It appears, therefore, that microsurgical removal is the technique of choice for operative treatment of CNS HBL.
In 23% of our patients, the CNS HBL was a manifestation of von Hippel-Lindau syndrome. This percentage of hereditary HBL is high compared to figures presented by Miiller-Jensen, et al., 8 Cramer and Kimsey, 3 Palmer, I~ Meredith and Hennigar, 7 and Silver and Hennigar, 12 who reported rates of 0%, 3.6%, 9.2%, 14.5%, and 22.5%, respectively. Our screening program, specifically designed for CNS HBL patients and their first-degree relatives, may have contributed significantly to this high percentage, since in many cases the diagnosis of von Hippel-Lindau syndrome was established only after completion of these examinations. On the other hand, endemic occurrence of von HippelLindau syndrome in southwest Germany cannot be excluded. Eighty-two percent of our HBL patients and seven of nine families in which von Hippel-Lindau syndrome was discovered during this study are living in this area with approximately 2 million inhabitants. Interestingly, Miiller-Jensen and coworkers, ~ who con- ducted a similar investigation in northern Germany, did not find a single case of hereditary HBL with von Hippel-Lindau syndrome. It has to be emphasized, however, that the diagnosis of this syndrome can easily be missed, particularly with an HBL of the CNS as the only manifestation of the syndrome in the patient and no detailed family history available. We were surprised by the lack of awareness among several affected families regarding the presence of a hereditary disease, despite extensive involvement of the whole kindred. Visceral manifestations of von Hippel-Lindau syndrome, such as pheochromocytomas, had obscured the identification of the phacomatosis in two of the families. Therefore, it is mandatory to rule out the syndrome in every individual with CNS HBL, irrespective of the patient's age, location of the tumor, and personal and family history. The only clinical features indicative of a higher probability of yon Hippel-Lindau syndrome are a young age at HBL diagnosis and multiplicity of CNS HBL's.
A standard screening examination as outlined in Table 1 includes a detailed family history and pedigree analysis; physical, neurological, and ophthalmological examinations (the latter with contact glass); abdominal ultrasound imaging; blood cell count; urinalysis; and 24-hour urinary excretion of catecholamines. For exploration of equivocal or pathological findings, cranial and abdominal CT scans and MR images and metaiodobenzylguanidine (MIBG) scintigraphs of the adrenal glands should be obtained. The minimum criteria of von Hippel-Lindau syndrome are fulfilled if an HBL patient displays an additional common manifestation of the syndrome (Table 5) . If this occurs, the patient's family should also undergo the standard screening program to identify additional members afflicted with the syndrome. Successful treatment of a CNS HBL offers a unique opportunity for persuading patients and their families to participate in such a program. Since 50% of all CNS HBL's require emergency neurosurgical treatment, early identification of this tumor in relatives would avoid such situations. To follow up on firstdegree relatives of HBL patients, annual cranial CT for all individuals at risk has been recommended. 4 We suggest a different regimen. After completing the screening examinations, family members of our patients are instructed to contact a physician immediately if focal neurological symptoms develop. Since local signs caused by the tumor have retrospectively occurred for an average of 25 weeks in our HBL patients, this strategy will facilitate early diagnosis and treatment of HBL in relatives at high risk. Initial results with this evaluation concept are encouraging since all three patients with von Hippel-Lindau-associated HBL treated in 1987 contacted us early after noticing initial signs of a cerebellar lesion.
